The international market tends to be local, and China has no worries about the future

According to the data released by China Chamber of Commerce for the import and export of pharmaceutical and health care products, in the first quarter of this year, the export amount of plant extracts reached 440 million US dollars, an increase of 44.3% year on year, accounting for 63.7% of the export share of traditional Chinese medicine; the export volume was 270000 tons, an increase of 52.3% year on year; the average export price declined slightly, a decrease of 5.3% year on year Plant extract is a new industry in the world In recent years, Chinese enterprises have made outstanding achievements in this field, and have a place in the international market The annual export volume has maintained a growth rate of more than 20% However, Zhang Chengwen, general manager of Xi'an Haotian Bioengineering Technology Co., Ltd and President of China plant extract association, expressed concern about the prospect of this fast-growing industry He said that after the international financial crisis, the three major markets in Europe, the United States and Japan showed a strong localization trend, and proposed new prices, costs and safety of plant products Requirement China's plant extract industry is the most likely sub industry to realize internationalization in the field of traditional Chinese medicine However, due to the disunity of standards and the lack of corresponding market supervision departments, it is difficult to form industry self-discipline and industrial concentration, resulting in many enterprises still staying in the scope of chemical enterprises He believes that the plant extract industry is in urgent need of national policy support Facing challenges, although the export of plant extracts has maintained a rapid growth from 2009 to the first quarter of this year, the future market is full of variables, which can be seen from this year's vitafoods exhibition in Europe and IFIA / he exhibition in Japan From the perspective of the European exhibition, although the overall market is not obviously affected by the economic difficulties, the market lacks new products Most of the products seen at the exhibition are old products and compound products improved on the basis of old products Omega-3 (unsaturated fatty acid) has become the mainstream product in European exhibitions With the popularization and promotion of local resource products dominated by bilberry and cranberry in Europe, the European market shows a trend of localization But the Chinese exhibition area is obviously neglected This indicates that the demand for traditional plant extract products in the European market is decreasing Customers pay more attention to international certification, product technical data and relevant clinical data in product selection, and brand products are favored Judging from the situation of the exhibition in Japan, the Japanese market is greatly affected by the economy In recent two years, the plant extraction industry has shrunk, and there are no more new products except for pigment products and plant derived ammonia sugar Fermentation and soybean products are still the mainstream products in the Japanese market Japan is the first market to accept Chinese plant extract products, but in recent years, due to the phenomenon of counterfeiting, Chinese products are under strict control Moreover, the Japanese market tends to abandon Chinese products and choose European products According to Zhang Chengcheng, Chinese enterprises are facing three major challenges in the international market First, the localization trend of each market: the European market highly values unsaturated fatty acid products, which are mainly produced in Nordic countries such as Norway; the Japanese market has become the mainstream of fermentation and bean products, while the Chinese market has few such products; the top seven products sold in the US market are all based on The American market tends to weaken Chinese products Second, the innovation speed of global plant lifting products is slow, and the price and cost become the focus of competition The days when Chinese enterprises used to rely on the star products launched by European and American companies every year to drive the market are gone forever Third, once China's plant lifting products become the synonym of "big goods" and "cheap goods", the market competitiveness will be difficult to guarantee and the future development will be worrying In terms of product transformation at home, the plant raising industry has been faced with resource problems According to the market survey report on the development of Chinese plant extract, Chinese plant extract enterprises are generally young, nearly 70% of them have entered the industry since 2001, and the rise of global plant extract industry is in the mid-1990s Compared with other sub industries of pharmaceutical industry, the development of China's plant extract industry is almost in line with the international From 1995 to 2000, China's plant extract products have been monopolized in the U.S market Plant extract products have also become the new force in the export of Chinese traditional medicine products in the past decade However, the plant extraction industry in China has been questioned from the very beginning According to an old researcher from the Chinese Academy of traditional Chinese medicine, the plant extraction industry wastes a lot of plant resources and has serious pollution, which should limit its development Zhang Chengcheng said that in the early stage of the development of China's plant lifting industry, there were indeed problems of resources and pollution However, with the improvement of the requirements of the international market for plant lifting products, the upgrading of products, the reduction of traditional resource products, and the gradual withdrawal of Chinese enterprises from resource products, the present plant lifting industry has undergone tremendous changes Zhang Chengwen gave a list of the top 50 planting products in the world He pointed out that in the top 50 products, fruit and fresh flower extracts and marine biological extracts accounted for 80% of the share, and the extracts of resource products with roots, stems and leaves as raw materials were few, while in the limited extracts of roots, stems and leaves, there were no cross varieties with common Chinese medicinal materials "As we all know, due to the medicinal value of taxol, Taxus in China has been facing resource depletion after several years of disorderly development, and the lessons are heavy Therefore, now the domestic plant lifting enterprises have reached a consensus, try not to develop rhizome products, but to turn to the development of fruits and leaves " Li Chunhua, chairman of Beijing Green Gold Biotechnology Co., Ltd., said The urgent need to support standards has always been a weakness of the planting and lifting industry in China, which has led to some products being questioned in the international market For example, one of the domestic standards of a product is 1:4, while the corresponding foreign indicators are 1:10 If the product is qualified in China, it may be judged as fake in the international market Therefore, the establishment of a unified standard and integration with the international market has become an urgent problem for the planting industry At present, there is no corresponding regulatory system for the plant lifting industry, and it still belongs to the chemical industry category Zhang Chengcheng believes that although the plant extraction industry is very small, its performance and development prospects in the export of traditional Chinese medicine are widely optimistic, and it is also a more realistic choice to realize the internationalization of traditional Chinese medicine He said that since last year, due to the lack of supervision in the domestic plant lifting market, there have been some bad signs, such as hoarding of raw materials, speculating on prices and so on, which have done great harm to the industry "In the face of the double pressure from the international and domestic markets, the plant and lift enterprises are very hopeful that the government will pay attention to and support them with policies We will improve the overall level of the industry through product registration and unified standards, encourage enterprises to strengthen cooperation, cultivate large enterprises, speed up environmental protection production, strengthen international certification and basic research, and improve innovation capacity " The head of the traditional Chinese Medicine Department of the chamber of Commerce for medical insurance also said that the plant extract industry is a sunrise industry and the scale of enterprises is not large In recent years, the chamber of commerce is committed to promoting exports, enhancing industrial concentration, and improving production standards It also hopes that relevant government departments will pay attention to this industry, strengthen market supervision, and guide the healthy development of the industry.